Lumibird S.A [LBIRD] vs bioMérieux S.A [BIM] Detailed Stock Comparison
Lumibird S.A
Euronext
Loading...
bioMérieux S.A
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Lumibird S.A wins in 4 metrics, bioMérieux S.A wins in 14 metrics, with 0 ties. bioMérieux S.A appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lumibird S.A | bioMérieux S.A | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 76.35 | 33.63 | bioMérieux S.A |
| Price-to-Book Ratio | 2.21 | 3.43 | Lumibird S.A |
| Debt-to-Equity Ratio | 81.34 | 11.65 | bioMérieux S.A |
| PEG Ratio | 36.09 | 26.78 | bioMérieux S.A |
| EV/EBITDA | 24.17 | 15.56 | bioMérieux S.A |
| Profit Margin (TTM) | 2.71% | 10.86% | bioMérieux S.A |
| Operating Margin (TTM) | 12.01% | 16.82% | bioMérieux S.A |
| EBITDA Margin (TTM) | 12.01% | 16.82% | bioMérieux S.A |
| Return on Equity | 2.91% | 10.68% | bioMérieux S.A |
| Return on Assets (TTM) | 2.23% | 7.23% | bioMérieux S.A |
| Free Cash Flow (TTM) | $11.41M | $321.50M | bioMérieux S.A |
| 1-Year Return | 98.59% | 28.16% | Lumibird S.A |
| Price-to-Sales Ratio (TTM) | 2.10 | 3.65 | Lumibird S.A |
| Enterprise Value | $526.68M | $14.75B | bioMérieux S.A |
| EV/Revenue Ratio | 2.51 | 3.71 | Lumibird S.A |
| Revenue per Share (TTM) | $10 | $34 | bioMérieux S.A |
| Earnings per Share (Diluted) | $0.26 | $3.64 | bioMérieux S.A |
| Beta (Stock Volatility) | 1.10 | 0.45 | bioMérieux S.A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Lumibird S.A vs bioMérieux S.A Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lumibird S.A | -0.76% | 4.51% | 8.84% | 69.83% | 159.21% | 105.21% |
| bioMérieux S.A | -0.32% | 0.48% | 4.79% | 7.78% | 8.43% | 21.42% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lumibird S.A | 98.59% | -10.05% | 64.72% | 574.66% | 875.25% | 875.25% |
| bioMérieux S.A | 28.16% | 22.08% | -9.64% | 259.06% | 496.65% | 496.65% |
Performance & Financial Health Analysis: Lumibird S.A vs bioMérieux S.A
| Metric | LBIRD | BIM |
|---|---|---|
| Market Information | ||
| Market Cap | €441.19M | €14.53B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 41,075 | 114,292 |
| 90 Day Avg. Volume | 40,991 | 107,663 |
| Last Close | €19.70 | €124.70 |
| 52 Week Range | €6.78 - €21.40 | €95.35 - €127.30 |
| % from 52W High | -7.94% | -2.04% |
| All-Time High | €24.35 (Dec 27, 2021) | €144.80 (Oct 12, 2020) |
| % from All-Time High | -19.10% | -13.88% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.03% | 0.09% |
| Quarterly Earnings Growth | -0.12% | 0.11% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.11% |
| Operating Margin (TTM) | 0.12% | 0.17% |
| Return on Equity (TTM) | 0.03% | 0.11% |
| Debt to Equity (MRQ) | 81.34 | 11.65 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €9.00 | €35.66 |
| Cash per Share (MRQ) | €3.24 | €3.81 |
| Operating Cash Flow (TTM) | €34.37M | €667.30M |
| Levered Free Cash Flow (TTM) | €6.75M | €297.79M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Lumibird S.A vs bioMérieux S.A
| Metric | LBIRD | BIM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 76.35 | 33.63 |
| Forward P/E | 36.09 | 26.78 |
| PEG Ratio | 36.09 | 26.78 |
| Price to Sales (TTM) | 2.10 | 3.65 |
| Price to Book (MRQ) | 2.21 | 3.43 |
| Market Capitalization | ||
| Market Capitalization | €441.19M | €14.53B |
| Enterprise Value | €526.68M | €14.75B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.51 | 3.71 |
| Enterprise to EBITDA | 24.17 | 15.56 |
| Risk & Other Metrics | ||
| Beta | 1.10 | 0.45 |
| Book Value per Share (MRQ) | €9.00 | €35.66 |
Financial Statements Comparison: Lumibird S.A vs bioMérieux S.A
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LBIRD | BIM |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LBIRD | BIM |
|---|---|---|
| Cash & Equivalents | €71.14M | €449.80M |
| Total Current Assets | €208.69M | €2.50B |
| Total Current Liabilities | €79.48M | €1.13B |
| Long-Term Debt | €142.03M | €349.20M |
| Total Shareholders Equity | €198.01M | €4.21B |
| Retained Earnings | €99.19M | €432.20M |
| Property, Plant & Equipment | €11.97M | €1.72B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LBIRD | BIM |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | LBIRD | BIM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 41,075 | 114,292 |
| Average Daily Volume (90 Day) | 40,991 | 107,663 |
| Shares Outstanding | 22.01M | 117.93M |
| Float Shares | 10.32M | 44.60M |
| % Held by Insiders | 0.57% | 0.63% |
| % Held by Institutions | 0.16% | 0.21% |
Dividend Analysis & Yield Comparison: Lumibird S.A vs bioMérieux S.A
| Metric | LBIRD | BIM |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |